Immuno-Modulation to Treat Common Cardiovascular Diseases: Moving From Sledgehammer to Precision Therapeutics

Affiliations

• ¹ Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia; St Vincent's Clinical School, UNSW Sydney, New South Wales, Australia; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: j.kovacic@victorchang.edu.au.
• ² Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), and Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, CIBERCV, Madrid, Spain.